Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: the TackSHS project protocol
Por:
Fernandez, E, Lopez, MJ, Gallus, S, Semple, S, Clancy, L, Behrakis, P, Ruprecht, A, Gorini, G, Lopez-Nicolas, A, Radu-Loghin, C, Soriano, JB, TackSHS Project Investigators
Publicada:
1 ene 2020
Resumen:
Objective: The TackSHS project aims to comprehensively elucidate the impact that exposure to second-hand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes have on the respiratory health of the European population according to socioeconomic characteristics and other determinants.
Method: The TackSHS project involves a series of coordinated studies carried out by 11 academic and public health organisations from six European countries. The project will investigate: a) the determinants of SHS and SHA exposure assessed at the individual level (surveys on representative general population samples) and in common environments (environmental sampling in specific settings): b) the overall disease burden, mortality and morbidity attributable to such exposure; and c) its economic impact in terms of direct health care costs. The project will also examine specific acute respiratory health changes in healthy individuals and patients with respiratoly diseases exposed to SHS and SHA. In addition, the project will examine the effectiveness of a novel intervention to reduce SHS exposure in households where smoking is permitted. All these studies are inter-related and involve collaborative coordination among the participant organisations.
Conclusion: The comprehensive, integrated approach of the TackSHS project will enable a significant step forward from the current status quo in the understanding of the impact of SHS and SHA exposure on health and provide the basis for health policy recommendations to help European countries to further reduce the harm caused by SHS and SHA exposure. (C) 2019 SESPAS. Published by Elsevier Espana, S.L.U.
Filiaciones:
Fernandez, E:
Inst Catala dOncol ICO, Lhospitalet De Llobregat, Barcelona, Spain
Inst dInvest Biomed Bellvitge IDIBELL, Lhospitalet De Llobregat, Barcelona, Spain
Univ Barcelona, Sch Med & Hlth Sci, Bellvitge Campus, Lhospitalet De Llobregat, Barcelona, Spain
Lopez, MJ:
Agencia Salut Publ Barcelona, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Inst dInvest Biomed St Pau IIB St Pau, Barcelona, Spain
Gallus, S:
Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy
Semple, S:
Univ Stirling, Inst Social Mkt, Stirling, Scotland
Clancy, L:
TobaccoFree Res Inst Ireland, Dublin, Ireland
Behrakis, P:
Hellen Canc Soc, George D Behrakis Res Lab, Athens, Greece
Ruprecht, A:
Fdn IRCCS Ist Nazl Tumori, Milan, Italy
Gorini, G:
Ist Studio Prevenz & Rete Oncol, Florence, Italy
Lopez-Nicolas, A:
Univ Politecn Cartagena, Cartagena, Spain
Radu-Loghin, C:
European Network Smoking & Tobacco Prevent, Brussels, Belgium
Soriano, JB:
Hosp Univ La Princesa, Resp Dept, Madrid, Spain
Gold, Green Accepted, Green Published
|